Alprenolol
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1011229/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1011229/Cv/1'> | ||
Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist,<ref name="a1">PMID:809360</ref> used in the treatment of angina pectoris.<ref name="a2">PMID:4393977</ref> See also [https://en.wikipedia.org/wiki/Alprenolol Alprenolol], [[Adrenergic receptor]], and [[5-hydroxytryptamine receptor]]. | Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist,<ref name="a1">PMID:809360</ref> used in the treatment of angina pectoris.<ref name="a2">PMID:4393977</ref> See also [https://en.wikipedia.org/wiki/Alprenolol Alprenolol], [[Adrenergic receptor]], and [[5-hydroxytryptamine receptor]]. | ||
| + | |||
| + | <scene name='10/1011229/Cv/2'>Human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol</scene> ([[3nya]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 09:51, 23 November 2023
| |||||||||||
References
- ↑ Elmros T, Hörstedt P, Winblad B. Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun. 1975 Sep;12(3):630-7. PMID:809360 doi:10.1128/iai.12.3.630-637.1975
- ↑ Hickie JB. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Med J Aust. 1970 Aug 8;2(6):268-72 PMID:4393977
